ACT-20-MSC
AHS 20-03
Phase 2 mab active
Quick answer
ACT-20-MSC for COVID-19 Pneumonia is a Phase 2 program (mab) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aspire Biopharma Holdings
- Indication
- COVID-19 Pneumonia
- Phase
- Phase 2
- Modality
- mab
- Status
- active